HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Internal Ribosome Entry Sites

Sequences within MESSENGER RNA that enable PROTEIN TRANSLATION INITIATION independent of 5' CAPPED RNA.
Also Known As:
Internal Ribosome Entry Site
Networked: 169 relevant articles (4 outcomes, 13 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Jan, Eric: 7 articles (01/2022 - 05/2006)
2. Prats, Anne-Catherine: 6 articles (12/2019 - 10/2004)
3. Hantelys, Fransky: 5 articles (12/2019 - 01/2014)
4. Garmy-Susini, Barbara: 4 articles (12/2019 - 01/2014)
5. Kieft, Jeffrey S: 4 articles (12/2016 - 05/2002)
6. Gera, Joseph: 4 articles (07/2016 - 01/2009)
7. Lichtenstein, Alan: 4 articles (07/2016 - 01/2009)
8. Morfoisse, Florent: 4 articles (01/2016 - 01/2014)
9. Schneider, Robert J: 4 articles (01/2016 - 11/2007)
10. Shi, Yijiang: 4 articles (01/2013 - 12/2008)

Related Diseases

1. Infections
2. Alzheimer Disease (Alzheimer's Disease)
04/20/2015 - "Potential natural products for Alzheimer's disease: targeted search using the internal ribosome entry site of tau and amyloid-β precursor protein."
12/01/2012 - "Effects of curcumin and demethoxycurcumin on amyloid-β precursor and tau proteins through the internal ribosome entry sites: a potential therapeutic for Alzheimer's disease."
12/01/2012 - "This study aims to determine the effects of curcumin and demethoxycurcumin on the internal ribosome entry site of the amyloid-β precursor protein (APP) and tau protein through a bi-cistronic reporter assay for screening of anti-Alzheimer's disease agents. "
12/01/2021 - ": m6A, N6-Methyladenosine; m6Am, N6,2'-O-Dimethyladenosine; m1A, N1-Methyladenosine; m5C, 5-Methylcytosine; hm5C, 5-Hydroxymethylcytosine; Ψ, pseudouridine; A-to-I, adenosine-to- inosine; hnRNPs, heterogeneous nuclear ribonucleoproteins; MOMP, mitochondrial outer membrane permeabilization; DD, death domain; DISC, death-inducing signalling complex; DED, death effector domain; FADD, FAS-associated protein with the death domain; TRADD, TNF receptor-associated protein with death domain; CMA, chaperone- mediated autophagy; PE, phosphatidylethanolamine; AD, alzheimer's disease; AML, acute myeloid leukaemia; miR, microRNA; 6-OHDA, 6-hydroxydopamine hydrochloride; R-2HG, R-2-hydroxyglutarate; IRES, internal ribosome entry site; BMSCs, bone-derived mesenchymal stem cells; NPCs, nucleus pulposus cells; HsCG, human chorionic gonadotropin; snoRNAs, small nucleolar RNAs; ER, endoplasmic reticulum; lncRNAs, long noncoding RNAs; TNM, tumour-node-metastasis."
3. Multiple Myeloma
4. Liver Cirrhosis (Hepatic Cirrhosis)
5. Ischemia

Related Drugs and Biologics

1. RNA (Ribonucleic Acid)
2. Amyloid (Amyloid Fibrils)
3. tau Proteins (tau Protein)
4. Curcumin
5. demethoxycurcumin
6. TOR Serine-Threonine Kinases
7. Cyclins
8. Antiviral Agents (Antivirals)
9. Proteins (Proteins, Gene)
10. Messenger RNA (mRNA)

Related Therapies and Procedures

1. Therapeutics
2. Radiotherapy
3. Drug Therapy (Chemotherapy)